Wealthfront’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Wealthfront's PFE Position: Q3 2018 in Review
Wealthfront increased its Pfizer (PFE) stake by 2.9% in Q3 2018, buying an estimated $227K and bringing the position to 207,245 shares worth $8.66M. The position accounts for 0.08% of the portfolio, ranked #41.
Wealthfront first reported a position in PFE in Q1 2014 and has held it in 19 quarters since. 2,257 funds tracked by Wall St. Rank hold PFE as of Q3 2018.
- Wealthfront held 207,245 shares of Pfizer worth $8.66M as of Q3 2018.
- Wealthfront bought 5,898 Pfizer shares in Q3 2018, an estimated $227K.
- Pfizer made up 0.08% of Wealthfront's portfolio in Q3 2018, its #41 holding.
- Wealthfront first reported a position in Pfizer in Q1 2014 and has held it in 19 quarters since.
- 2,257 funds tracked by Wall St. Rank held Pfizer as of Q3 2018.
Based on Wealthfront's 13F filing for Q3 2018, filed 13 Nov 2018.